News

MPR
empr. com > news > chronic-cannabis-smoking-thc-ingestion-linked-to-endothelial-dysfunction

Chronic Cannabis Smoking, THC Ingestion Linked to Endothelial Dysfunction

10+ mon, 1+ week ago  (246+ words) Arterial flow-mediated dilation was significantly lower among marijuana smokers and THC-edible users than among nonusers. Health Day News " Chronic cannabis smoking and tetrahydrocannabinol (THC). .. Health Day News " Chronic cannabis smoking and tetrahydrocannabinol (THC) ingestion are associated with endothelial dysfunction, according…...

MPR
empr. com > news > spironolactone-does-not-reduce-risk-for-cardiovascular-morbidity-mortality-in-patients-on-dialysis

Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis

7+ mon, 2+ week ago  (298+ words) No reduction seen in the composite outcome of cardiovascular mortality, hospitalization due to heart failure. Health Day News " Spironolactone does not reduce a composite outcome of cardiovascular. .. Health Day News " Spironolactone does not reduce a composite outcome of cardiovascular mortality…...

MPR
empr. com > news > vedolizumab-promising-for-pediatric-ulcerative-colitis-after-soc-failure

Vedolizumab Promising for Pediatric Ulcerative Colitis After SOC Failure

1+ mon, 3+ week ago  (269+ words) Topline results were announced from a phase 3 study evaluating vedolizumab in the treatment of moderate to severe ulcerative colitis (UC) in children and adolescents. Vedolizumab, an integrin receptor antagonist, is currently approved under the brand name Entyvio" "for the treatment…...

MPR
empr. com > news > sofetabart-mipitecan-gets-breakthrough-tx-status-for-platinum-resistant-ovarian-cancer

Sofetabart Mipitecan Gets Breakthrough Tx Status for Platinum-Resistant Ovarian Cancer

2+ mon, 3+ week ago  (351+ words) The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible....

MPR
empr. com > news > glp-1-receptor-agonists-may-lower-risk-for-worsening-mental-illness

GLP-1 Receptor Agonists May Lower Risk for Worsening Mental Illness

2+ week, 4+ day ago  (342+ words) Findings were seen in individuals already diagnosed with depression, anxiety. Health Day News " Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced. .. Health Day News " Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced…...

MPR
empr. com > news > blaine-labs-recalls-wound-care-gels-due-to-microbial-contamination

Blaine Labs Recalls Wound Care Gels Due to Microbial Contamination

9+ hour, 7+ min ago  (265+ words) The contaminated products, distributed exclusively to physician offices, may increase the risk for infection, skin irritation, or delayed wound healing. Blaine Labs is voluntarily recalling certain lots of Revitaderm" Wound Care Antiseptic Gel (benzalkonium chloride 0. 1%) and Tridergel" Wound Care Gel…...

MPR
empr. com > news > guidelines-updated-on-use-of-parenteral-meds-for-migraine-in-emergency-department

Guidelines Updated on Use of Parenteral Meds for Migraine in Emergency Department

4+ mon, 1+ day ago  (315+ words) Guideline states that prochlorperazine IV and greater occipital nerve blocks must be offered to eligible adults requiring parenteral therapy. Health Day News " The American Headache Society has updated. .. Health Day News " The American Headache Society has updated the guidelines on…...

MPR
empr. com > news > fluvoxamine-improves-fatigue-qol-in-long-covid

Fluvoxamine Improves Fatigue, Qo L in Long COVID

1+ week, 15+ hour ago  (281+ words) Health Day News " For patients with postacute sequelae of SARS-Co V-2, fluvoxamine seems effective for reducing fatigue and improving quality of life (Qo L), according to a study published online March. .. Health Day News " For patients with postacute sequelae of SARS-Co V-2, fluvoxamine…...

MPR
empr. com > news > gefurulimab-improves-daily-functional-abilities-in-generalized-myasthenia-gravis

Gefurulimab Improves Daily Functional Abilities in Generalized Myasthenia Gravis

8+ mon, 2+ week ago  (172+ words) Generalized myasthenia gravis (g MG) is a rare autoimmune disease characterized by symptoms such as slurred speech, double vision, muscle weakness, droopy eyelids and lack of balance. Gefurulimab is a dual-binding nanobody designed to bind to the C5 protein in the…...

MPR
empr. com > news > secukinumab-looks-promising-for-polymyalgia-rheumatica

Secukinumab Looks Promising for Polymyalgia Rheumatica

5+ mon, 3+ week ago  (378+ words) Findings showed secukinumab demonstrated statistically significant and clinically meaningful sustained remission at week 52 vs placebo. Topline data were announced from a phase 3 trial evaluating. .. Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica (PMR)....